Results:
fatigue
ADVERSE REACTIONS
34 participants were randomised over 16 months (17 iron, 17 placebo). Among
those eligible 47% of people agreed to participate and total study attrition
was 26%. Blinding was successful in all participants. There were no serious
adverse reactions. Results indicated that intravenous iron may be
efficacious at improving participant haemoglobin, iron stores and select
fatigue specific quality of life measures compared to placebo.